Elevate Uranium Ltd (AU:EL8)
ASX:EL8
Top Page
Elevate Uranium Ltd
(Sydney:EL8)
Select Model
Select Model
Rating:43Neutral
Price Target:
AU$0.29
▼(-14.71% Downside)
Action:ReiteratedDate:03/24/26
The score is primarily held back by weak financial performance (ongoing losses and negative operating/free cash flow) and bearish technical signals (trading below major moving averages with negative MACD). Valuation provides limited support because the company is loss-making and no dividend yield is available.
Positive Factors
Low leverage
Conservative leverage provides durable financial flexibility for a development-stage miner: low debt reduces refinancing and covenant risk while preserving the ability to fund exploration or studies via equity or project finance. This supports project advancement over the next 2–6 months without heavy interest burdens.
Negative Factors
Negative cash flow
Persistent negative operating and free cash flow signals ongoing funding requirements and limited internal cash generation. Over the medium term this will necessitate equity raises or partner financing, which can dilute shareholders and slow project timelines if capital conditions tighten or projects need more advanced studies.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage
Conservative leverage provides durable financial flexibility for a development-stage miner: low debt reduces refinancing and covenant risk while preserving the ability to fund exploration or studies via equity or project finance. This supports project advancement over the next 2–6 months without heavy interest burdens.
Read all positive factors
Elevate Uranium Ltd (EL8) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$132.80M
Dividend YieldN/A
Average Volume (3M)1.69M
Price to Earnings (P/E)―
Beta (1Y)2.70
Revenue GrowthN/A
EPS Growth1.38%
CountryAU
Employees20
SectorEnergy
Sector Strength52
IndustryUranium
Share Statistics
EPS (TTM)-0.01
Shares Outstanding465,968,100
10 Day Avg. Volume1,984,434
30 Day Avg. Volume1,688,761
Financial Highlights & Ratios
PEG Ratio2.09
Price to Book (P/B)4.73
Price to Sales (P/S)147.04
P/FCF Ratio-9.65
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Elevate Uranium Ltd Business Overview & Revenue Model
Company Description
Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits. The company's principal projects include the Koppies, Hirabeb, Marenica, and Namib IV in Namibia. It also holds 100% interests in the Angela, Thatcher Soak, Oobagoo...
How the Company Makes Money
Elevate Uranium is a pre-revenue minerals exploration and development company; it does not typically generate recurring operating revenue from selling products or services while it is exploring and evaluating deposits. If it were to make money, it...
Elevate Uranium Ltd Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
40
Negative
Cash Flow
30
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 768.50K | 768.50K | 182.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 813.11K | 768.50K | -121.67K | -117.68K | -85.52K | -54.29K |
| EBITDA | -11.03M | -11.85M | -10.62M | -8.51M | -5.68M | -2.66M |
| Net Income | -10.99M | -12.32M | -10.75M | -8.63M | -5.73M | -2.60M |
Balance Sheet | ||||||
| Total Assets | 45.64M | 25.46M | 13.26M | 12.54M | 19.33M | 9.96M |
| Cash, Cash Equivalents and Short-Term Investments | 36.65M | 21.71M | 10.83M | 10.06M | 15.81M | 6.66M |
| Total Debt | 390.56K | 432.41K | 74.21K | 146.03K | 177.27K | 99.29K |
| Total Liabilities | 1.52M | 1.57M | 1.48M | 1.02M | 838.59K | 429.54K |
| Stockholders Equity | 44.12M | 23.89M | 11.78M | 11.52M | 18.49M | 9.53M |
Cash Flow | ||||||
| Free Cash Flow | -13.74M | -11.71M | -9.31M | -5.90M | -4.49M | -2.40M |
| Operating Cash Flow | -13.27M | -11.62M | -9.24M | -5.83M | -4.38M | -2.33M |
| Investing Cash Flow | -3.50M | -714.24K | -73.79K | -74.52K | -137.62K | -61.28K |
| Financing Cash Flow | 23.13M | 23.22M | 10.09M | 158.86K | 13.67M | 7.99M |
Elevate Uranium Ltd Technical Analysis
Neutral
0.34
Price Trends
0.34
Negative
0.32
Negative
0.32
Negative
Market Momentum
-0.01
Negative
49.72
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:EL8, the sentiment is Neutral. The current price of 0.34 is above the 20-day moving average (MA) of 0.29, below the 50-day MA of 0.34, and above the 200-day MA of 0.32, indicating a neutral trend. The MACD of -0.01 indicates Negative momentum. The RSI at 49.72 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for AU:EL8.
Elevate Uranium Ltd Peers Comparison
UnderperformOutperform
Sector (65)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
46 Neutral | AU$232.57M | -2.14 | -10.95% | ― | -100.00% | 49.49% | |
46 Neutral | AU$18.66M | -30.09 | -1.07% | ― | ― | 8.33% | |
45 Neutral | AU$218.68M | -16.35 | -12.34% | ― | ― | -67.12% | |
44 Neutral | AU$132.53M | -6.08 | -17.88% | ― | ― | -75.25% | |
43 Neutral | AU$132.80M | -4.98 | -32.33% | ― | ― | 1.38% | |
40 Underperform | AU$7.18M | -2.50 | -82.81% | ― | ― | -141.67% |
* Energy Sector Average
AU:EL8
Elevate Uranium Ltd
0.29
0.06
29.55%
AU:AEE
Aura Energy
0.13
0.02
13.04%
AU:BKY
Berkeley Energia
0.49
-0.09
-15.52%
AU:PEN
Peninsula Energy
0.52
0.04
7.22%
AU:ZEU
Zeus Resources Ltd.
0.01
0.00
0.00%
AU:EME
Energy Metals Ltd
0.09
0.03
43.55%
Elevate Uranium Ltd Corporate Events
Elevate Uranium Moves General Meeting Materials Fully Online
Apr 9, 2026
Elevate Uranium Ltd has called a general meeting of shareholders for 8 May 2026 in West Perth, with proxy forms and communication preference notices to be sent separately by its share registry, Automic. In line with Australian corporate law, the c...
Elevate Uranium Moves to Digital-First Shareholder Meeting Process
Apr 9, 2026
Elevate Uranium Ltd has called a general meeting of shareholders to be held on 8 May 2026 in West Perth, setting 6 May 2026 as the record date to determine voting eligibility. The company is shifting to electronic distribution of meeting documents...
Elevate Uranium Releases Half-Year Financial Report for December 2025
Mar 12, 2026
Elevate Uranium Ltd has released its half-year financial report for the period ended 31 December 2025, providing consolidated financial statements and accompanying notes. The report includes profit or loss and other comprehensive income, financial...
Elevate Uranium Builds Critical Mass With 153Mlb Global Resource Base
Feb 8, 2026
Elevate Uranium has outlined a global resource base of 153 million pounds of U3O8 across two top‑tier jurisdictions, positioning itself as an emerging mid‑tier player in the uranium sector. The company reports four discoveries in four ...
Elevate Uranium Doubles Resource Grade at Namibia’s Marenica Project After Major Re-Estimate
Feb 4, 2026
Elevate Uranium has delivered a major upgrade to the Mineral Resource Estimate at its Marenica Uranium Project in Namibia, doubling the resource grade to 185 ppm U3O8 for 40.2 million pounds of contained uranium at a 100 ppm cut-off grade, and inc...
Elevate Uranium Options Lapse, Clarifying Capital Structure
Feb 3, 2026
Elevate Uranium Ltd has confirmed the expiry of 14,904,798 listed options (ASX code EL8AT), which were due to expire on 30 January 2026 with an exercise price of A$0.60 and lapsed without being exercised. The cessation of these options reduces the...
Elevate Uranium Options Lapse Simplifies Capital Structure
Feb 3, 2026
Elevate Uranium Ltd has confirmed that 14,904,798 unlisted Class EL8AT options, each exercisable at $0.60, expired on 30 January 2026. The lapse of these options marginally simplifies the company’s capital structure by removing a tranche of ...
Elevate Uranium Managing Director Increases Indirect Shareholding via Super Fund
Jan 22, 2026
Elevate Uranium Limited has disclosed changes in the securities held by Managing Director Murray Hill and his related entities, including his spouse and their self-managed superannuation fund. The notice details a net acquisition of 1,349,486 full...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.